Yun Zhong

Stock Analyst at Wedbush

(0)
# 4731
Out of 5,243 analysts
43
Total ratings
19.05%
Success rate
-21.74%
Average return
Main Sectors:
Top Industries:
21 Stocks
Name Action Price Target Current % Upside Ratings Updated
Passage Bio
Assumes: Outperform
4
0.58 589.66% 2 Nov 29, 2024
MoonLake
Assumes: Outperform
92 73
45.87 59.15% 1 Nov 5, 2024
Rezolute
Initiates Coverage On: Outperform
12
4.68 156.41% 1 Nov 5, 2024
Protagonist Therapeu...
Initiates Coverage On: Outperform
58
37.83 53.32% 1 Nov 5, 2024
Anavex Life Sciences
Maintains: Buy
35 28
11.34 146.91% 2 Feb 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Feb 2, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 5 Jan 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jan 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
14 16
9.32 71.67% 1 Jan 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
125 160
119.7 33.67% 9 Dec 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
48
n/a n/a 3 Dec 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
35
10.73 226.19% 1 Nov 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Sep 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Sep 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
150 75
n/a n/a 2 Aug 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
700
8.14 8499.51% 2 Jul 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
46
13.73 235.03% 1 Jun 15, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
n/a n/a 1 Jun 15, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
8
n/a n/a 1 Jun 15, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
3.1 222.58% 1 May 5, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
34
n/a n/a 1 Aug 22, 2018